Atomistry » Fluorine » PDB 3u5k-3uxm » 3u6j
Atomistry »
  Fluorine »
    PDB 3u5k-3uxm »
      3u6j »

Fluorine in PDB 3u6j: Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor

Enzymatic activity of Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor

All present enzymatic activity of Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor:
2.7.10.1;

Protein crystallography data

The structure of Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor, PDB code: 3u6j was solved by D.A.Whittington, A.Long, P.Rose, Y.Gu, H.Zhao, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.00 / 2.15
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 56.194, 65.268, 57.323, 90.00, 117.94, 90.00
R / Rfree (%) 19.3 / 23

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor (pdb code 3u6j). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor, PDB code: 3u6j:

Fluorine binding site 1 out of 1 in 3u6j

Go back to Fluorine Binding Sites List in 3u6j
Fluorine binding site 1 out of 1 in the Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of the VEGFR2 Kinase Domain in Complex with A Pyrazolone Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1

b:30.2
occ:1.00
F1 A:03X1 0.0 30.2 1.0
C13 A:03X1 1.4 29.8 1.0
C10 A:03X1 2.4 29.5 1.0
C14 A:03X1 2.4 29.3 1.0
O1 A:03X1 2.8 29.8 1.0
CG2 A:VAL848 3.4 34.0 1.0
C9 A:03X1 3.4 29.2 1.0
CG1 A:VAL848 3.5 33.9 1.0
C8 A:03X1 3.5 29.4 1.0
C17 A:03X1 3.6 29.2 1.0
C15 A:03X1 3.7 29.2 1.0
OG1 A:THR916 3.7 28.9 1.0
CB A:ALA866 3.8 32.5 1.0
CB A:VAL848 4.0 35.0 1.0
C16 A:03X1 4.1 29.2 1.0
CB A:LYS868 4.2 30.6 1.0
N A:LYS868 4.5 30.6 1.0
C A:ALA866 4.5 32.2 1.0
O A:ALA866 4.5 31.5 1.0
C5 A:03X1 4.7 29.5 1.0
CE A:LYS868 4.7 29.3 1.0
C7 A:03X1 4.7 29.4 1.0
CA A:LYS868 4.7 30.7 1.0
CA A:ALA866 4.8 33.1 1.0
N2 A:03X1 4.8 29.4 1.0
C A:VAL867 4.8 31.2 1.0
N A:VAL867 4.8 32.0 1.0
CB A:THR916 4.9 27.8 1.0
O4 A:03X1 4.9 29.1 1.0
CA A:VAL848 5.0 35.3 1.0

Reference:

M.H.Norman, L.Liu, M.Lee, N.Xi, I.Fellows, N.D.D'angelo, C.Dominguez, K.Rex, S.F.Bellon, T.S.Kim, I.Dussault. Structure-Based Design of Novel Class II C-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives. J.Med.Chem. V. 55 1858 2012.
ISSN: ISSN 0022-2623
PubMed: 22320343
DOI: 10.1021/JM201330U
Page generated: Mon Jul 14 19:40:41 2025

Last articles

Mg in 5IUJ
Mg in 5IUC
Mg in 5IU0
Mg in 5IT5
Mg in 5ITZ
Mg in 5IT3
Mg in 5IT4
Mg in 5IQI
Mg in 5IT0
Mg in 5IS2
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy